Please assess the completion status of the following clinical trial:

Trial Title: Oral Therapies in Oncology: Cognitive Function and Compliance

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age over 18 years,~* Patients treated with a first prescription of exclusive oral therapy (chemotherapy and/or targeted therapy) as part of a cancer,~* Patients who begin treatment with ZYTIGA ® (abiraterone acetate) are incluables,~* Patients with asymptomatic brain metastases are incluables,~* Lack of personality disorders and psychiatric illness scalable,~* Knowledge of spoken and written French,~* Having signed the informed consent of study participation.~Exclusion Criteria:~* Pathology psychiatric~* Refusal to participate,~* Patient unable to respond to cognitive tests, - Documented use of drugs,~* Heavy drinking, - Cancer primitive central nervous system, - Participation in a clinical trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).